4119 Cholecystokinin (CCK) Receptor Antagonist Reverses Nonalcoholic Steatohepatitis (NASH) by Reducing Hepatic Macrophages and Inflammatory Cytokines

OBJECTIVES/GOALS: NASH increases the risk of cirrhosis and liver cancer. High-fat diets increase CCK levels and CCK receptors have been identified on fibroblasts and immune cells. We hypothesized that CCK receptor blockade could prevent NASH by altering the hepatic microenvironment and macrophage ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Gay, Martha, Safronenka, Anita, Cao, Hong, Tucker, Robin, Shivapurkar, Narayan, Kruger, Annie, Smith, Jill
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2020
Materias:
Mechanistic Basic to Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8823289/
http://dx.doi.org/10.1017/cts.2020.293

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8823289/
http://dx.doi.org/10.1017/cts.2020.293

Ejemplares similares